Botulinum Neurotoxin for Pain Management: Insights from Animal Models
The action of botulinum neurotoxins (BoNTs) at the neuromuscular junction has been extensively investigated and knowledge gained in this field laid the foundation for the use of BoNTs in human pathologies characterized by excessive muscle contractions. Although much more is known about the action of...
Main Authors: | Siro Luvisetto, Flaminia Pavone |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-12-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/2/12/2890/ |
Similar Items
-
Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy
by: Siro Luvisetto
Published: (2021-10-01) -
Botulinum Neurotoxins beyond Neurons: Interplay with Glial Cells
by: Siro Luvisetto
Published: (2022-10-01) -
Botulinum Toxin Type A as a Therapeutic Agent against Headache and Related Disorders
by: Siro Luvisetto, et al.
Published: (2015-09-01) -
Botulinum Neurotoxin for the Treatment of Neuropathic Pain
by: Gabriella Egeo, et al.
Published: (2020-08-01) -
Effects of Botulinum Toxin Type A on the Nociceptive and Lemniscal Somatosensory Systems in Chronic Migraine: An Electrophysiological Study
by: Gabriele Sebastianelli, et al.
Published: (2023-01-01)